In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination

We explore the contentious life of a metric used to assess a country’s progress in relation to global disease elimination targets. Our topic is hepatitis C elimination, and our context is Australia. A fundamental metric in the calculation of progress toward hepatitis C elimination targets, as set by...

Full description

Saved in:
Bibliographic Details
Main Authors: Tim Rhodes, Kari Lancaster, Sophie Adams
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/9/2/e014659.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850095732940341248
author Tim Rhodes
Kari Lancaster
Sophie Adams
author_facet Tim Rhodes
Kari Lancaster
Sophie Adams
author_sort Tim Rhodes
collection DOAJ
description We explore the contentious life of a metric used to assess a country’s progress in relation to global disease elimination targets. Our topic is hepatitis C elimination, and our context is Australia. A fundamental metric in the calculation of progress toward hepatitis C elimination targets, as set by the WHO, is the population prevalence of people living with hepatitis C. In Australia, this modelled estimate has generated some controversy, largely through its repeated downsizing as an effect of calculus. The 2015 baseline population estimate in Australia, from which measures of current elimination progress are assessed, has reduced, over time, by around 30%. Informed by a social study of science approach, we used qualitative interviews with 32 experts to explore the knowledge controversy. The controversy is narrated through the core concerns of ‘scale’ and ‘care’, with narratives aligning differently to imaginaries of ‘science’ and ‘community’. We trace how constitutions of ‘estimate’ and ‘number’ circulate in relation to ‘population’ and ‘people’, and as affective values. We show how enactments of estimates and numbers materialise hepatitis elimination in different ways, with policy implications. The event of the knowledge controversy opens up the social and political life of enumerations—for science and community—inviting deliberation on how to make ‘good numbers’ in the race to eliminate hepatitis C.
format Article
id doaj-art-4da7bc8ef1724a73a2bacde6e8a2d4c1
institution DOAJ
issn 2059-7908
language English
publishDate 2024-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Global Health
spelling doaj-art-4da7bc8ef1724a73a2bacde6e8a2d4c12025-08-20T02:41:23ZengBMJ Publishing GroupBMJ Global Health2059-79082024-02-019210.1136/bmjgh-2023-014659In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C eliminationTim Rhodes0Kari Lancaster1Sophie Adams2Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, AustraliaCentre for Social Research in Health, University of New South Wales, Sydney, New South Wales, AustraliaDeakin University, Burwood, AustraliaWe explore the contentious life of a metric used to assess a country’s progress in relation to global disease elimination targets. Our topic is hepatitis C elimination, and our context is Australia. A fundamental metric in the calculation of progress toward hepatitis C elimination targets, as set by the WHO, is the population prevalence of people living with hepatitis C. In Australia, this modelled estimate has generated some controversy, largely through its repeated downsizing as an effect of calculus. The 2015 baseline population estimate in Australia, from which measures of current elimination progress are assessed, has reduced, over time, by around 30%. Informed by a social study of science approach, we used qualitative interviews with 32 experts to explore the knowledge controversy. The controversy is narrated through the core concerns of ‘scale’ and ‘care’, with narratives aligning differently to imaginaries of ‘science’ and ‘community’. We trace how constitutions of ‘estimate’ and ‘number’ circulate in relation to ‘population’ and ‘people’, and as affective values. We show how enactments of estimates and numbers materialise hepatitis elimination in different ways, with policy implications. The event of the knowledge controversy opens up the social and political life of enumerations—for science and community—inviting deliberation on how to make ‘good numbers’ in the race to eliminate hepatitis C.https://gh.bmj.com/content/9/2/e014659.full
spellingShingle Tim Rhodes
Kari Lancaster
Sophie Adams
In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination
BMJ Global Health
title In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination
title_full In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination
title_fullStr In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination
title_full_unstemmed In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination
title_short In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination
title_sort in search of a good number knowledge controversy and population estimates in the endgame of hepatitis c elimination
url https://gh.bmj.com/content/9/2/e014659.full
work_keys_str_mv AT timrhodes insearchofagoodnumberknowledgecontroversyandpopulationestimatesintheendgameofhepatitiscelimination
AT karilancaster insearchofagoodnumberknowledgecontroversyandpopulationestimatesintheendgameofhepatitiscelimination
AT sophieadams insearchofagoodnumberknowledgecontroversyandpopulationestimatesintheendgameofhepatitiscelimination